Global Sepsis Diagnostics Market size was valued at US$ 429 Mn in 2019 and the total revenue is expected to grow at XX% through 2020 to 2026, reaching nearly US$ 975 Mn.
The global Sepsis Diagnostics market report is a comprehensive analysis of the industry, market, and key players. The report has covered the market by demand and supply-side by segments. The global Sepsis Diagnostics market report also provides trends by market segments, Technology Type, and investment with a competitive landscape.
To know about the Research Methodology :- Request Free Sample Report
Global Sepsis Diagnostics Market Overview
Sepsis is the body’s extreme and intense immune response to an infection and is termed as a life-threatening medical emergency. Sepsis occurs when a person suffering from an infection already triggers a chain reaction in the whole body. The absence of timely diagnosis and treatment of sepsis can lead to the damage of body tissues, organ failure, and even death. Symptoms of sepsis include high fever, difficulty in breathing, low blood pressure, increased heart rate, and mental confusion. As for treatment, doctors administer antibiotics and intravenous fluids. According to the data published by WHO over 30 million individuals globally suffered from sepsis with a mortality rate of 5% in 2018. It also states that approximately 3 million infants and 1.2 Million children suffer from sepsis.
It is also a blood infection considered more dangerous than heart attacks and cancer. More common in people who have a weak immune system, pregnant women, very young people, geriatric population, especially those with health problems diabetic patients, and others. A lack of blood oxygen and problems in the kidney or liver are some other symptoms.
Global Sepsis Diagnostics Market Dynamics
Major growth factors for the market growth include Hospital-acquired infection. Especially, in old age people, infants, and people suffering from co-morbidities. As per data published by (CDC) Center for Disease and Control of America, more than 1.5 million people suffer from HAI, around 99,000 patients succumbed because of inadequate medical care in the US alone. With the outbreak of COVID-19 which weakens the immune system over time the infected person triggered the chances of sepsis in patients.
Furthermore, increased regulatory approval and technically advanced diagnostic solutions impacted positively on the market’s growth. Most of the revenue for the market comes from diagnosis and treatment procedures of sepsis. Moreover, increased demand for rapid and POC test kits for the early detection of sepsis that can save millions of lives triggered the overall market growth.
Besides this increased industrial development and new methods of diagnosis further propelled the market growth. For example, Barcelona-based Loop diagnostics in 2020 developed a point of care diagnosis system with the company claiming that the product would replace the traditional blood culture method of analysis. The main idea was to detect bacterial infection based on blood marks and can provide results in 2 hours with an accuracy of 99%. As per the data around 1 million people annually are diagnosed with Sepsis in India. Due to which the market has noted substantial growth. However, certain factors such as high costs related to the treatment of sepsis and often delays in the diagnostic results of sepsis are restraining the market growth.
Global Sepsis Diagnostics Market Segment Analysis
Based on the Product Type, the segment of blood culture media held the largest market share in 2020 and is anticipated to dominate during the forecast period due to its convenience and cost-effective nature in diagnosing sepsis in patients and is highly preferred by physicians. The segment of Kits and reagents is expected to grow fastest due to increased demand for testing kits and reagents that deliver quick results. As per the data of (AMA) American Medical Association, sepsis caused the death of 1.7 MN people in the US. Which triggered kit and reagents market growth. The software segment is anticipated to register the highest growth in the market due to an increase in the adoption of software systems by healthcare professionals for better results.
Based on Technology, the microbiology segment held the largest share in 2019. This is because microbiology technology provides the most accurate detection & identification of microorganisms for the diagnosis of sepsis by using the application of blood culture media tests. Additionally, new strategic initiatives by market key players are driving the segment during the forecast period. Moreover, Increased preference for molecular diagnostic technology because of its advantages such as high accuracy, sensitivity, and less time taken impacted positively on the growth of the molecular diagnostic market. And is the most preferred pathogen technique after blood culture by the clinicians.
By Testing Type, laboratory tests dominated the market in recent years because of the fact that laboratory tests provide the result with higher accuracy for diagnosing sepsis as compared to other tests. Laboratory test provides results after the in-depth analysis of pathogens. With the availability of technologically advanced diagnosis solutions, the dependency of people and physicians on these labs have subsequently increased. Whereas, by pathogens segment of bacterial sepsis is dominating the market due to its high prevalence according to the study published by SAGE journal sepsis is the most common type of bacteria with 60% infected with gram-negative and 46% with gram-positive bacteria.
Global Sepsis Diagnostics Market 1
Global Sepsis Diagnostics Market Regional Insights:
North America and Europe accounted for the highest market share and is anticipated to continue its lead during the forecast period. The growth of the region can be attributed to the well-established and continuously developing healthcare system and infrastructure, which has triggered the adoption of technologically advanced and innovative diagnostic solutions that provide quick results in the region. Additionally, the presence of key players and a supportive framework for reinforcements and government support in this region are further impacting positively on the market’s growth. As per the data available, incidences of sepsis and other infectious diseases are high in the US which has fuelled the demand for novel diagnostic solutions.
The Asia Pacific is anticipated to be the fastest-growing region in the market during the forecast period. Due to the growing demand for sepsis diagnostic solutions and rapid/POC test kits in developing countries with a high prevalence of sepsis and other infectious diseases, such as China and India. Additionally, the outbreak of COVID-19 in these countries triggered the chances of sepsis in the region. The market is also evolving because of increased initiatives taken by regional and international players to improve laboratory testing and automation solutions. However, a lack of awareness in underdeveloped countries of the region is restraining the market growth.
Global Sepsis Diagnostics Market 2
The objective of the report is to present a comprehensive analysis of the Global Sepsis Diagnostics Capsule market to the stakeholders in the industry. The past and current status of the industry with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants.
PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers.
The report also helps in understanding the Global Sepsis Diagnostics Market dynamics, structure by analyzing the market segments and project the Global Sepsis Diagnostics Market size. Clear representation of competitive analysis of key players by Technology, price, financial position, Technology portfolio, growth strategies, and regional presence in the Global Sepsis Diagnostics Market make the report investor’s guide.
For more information of visit:https://www.maximizemarketresearch.com/market-report/global-sepsis-diagnostics-market/112617/
Global Sepsis Diagnostics Market Scope: Inquire before buying
Global Sepsis Diagnostics Market 3
Global Sepsis Diagnostics Market, by Region
• North America
• Asia Pacific
• Middle East and Africa
• South America
Global Sepsis Diagnostics Market Key Players
• Axis-Shield Diagnostics
• Becton Dickinson
• Danaher Corporation
• Abbott Laboratories
• Thermo Fisher Scientific
• EKF Diagnostics
• Roche Diagnostics
• T2 Biosystems
• Response Biomedical,
• Mckesson Corporation
Maximize Market Research offers customization of reports according to the specific requirement of our clients.
This Report Is Submitted By : Maximize Market Research Company Customization of the report: Maximize Market Research provides free personalized of reports as per your demand. This report can be personalized to meet your requirements. Get in touch with us and our sales team will guarantee provide you to get a report that suits your necessities.
About Maximize Market Research: Maximize Market Research provides B2B and B2C research on 20,000 high growth emerging opportunities & technologies as well as threats to the companies across the Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors.